111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging

被引：107

作者：

Bombardieri, Emilio ^{[10
]}

Ambrosini, Valentina ^{[9
]}

Aktolun, Cumali ^{[8
]}

Baum, Richard P. ^{[7
]}

Bishof-Delaloye, Angelica ^{[6
]}

Del Vecchio, Silvana ^{[5
]}

Maffioli, Lorenzo ^{[4
]}

Mortelmans, Luc ^{[3
]}

Oyen, Wim ^{[2
]}

Pepe, Giovanna ^{[1
]}

Chiti, Arturo ^{[1
]}

机构：

[1] Ist Clin Humanitas, Milan, Italy

[2] Radboud Univ Nijmegen, Nijmegen, Netherlands

[3] Univ UZ Gasthuisberg, Louvain, Belgium

[4] Osped Legnano, Legnano, Italy

[5] Univ Naples Federico 2, Naples, Italy

[6] CHUV, Lausanne, Switzerland

[7] PET Ctr, Bad Berka, Germany

[8] Univ Kocaeli, Kocaeli, Turkey

[9] S Orsola Malpighi Univ Hosp, Bologna, Italy

[10] Ist Nazl Studio & Cura Tumori, Milan, Italy

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2010年 / 37卷 / 07期

关键词：

In-111-pentetreotide scintigraphy; Tumour imaging; Procedure guidelines; Neuroendocrine tumours; Indications; SOMATOSTATIN RECEPTOR SCINTIGRAPHY; NEUROENDOCRINE GASTROENTEROPANCREATIC TUMORS; CARCINOID-TUMORS; ANALOG SCINTIGRAPHY; ENDOCRINE TUMORS; MANAGEMENT; INDIUM-111-PENTETREOTIDE; EXPRESSION; IMPACT; GASTRINOMAS;

D O I：

10.1007/s00259-010-1473-6

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

This document provides general information about somatostatin receptor scintigraphy with In-111-pentetreotide. This guideline should not be regarded as the only approach to visualise tumours expressing somatostatin receptors or as exclusive of other nuclear medicine procedures useful to obtain comparable results. The aim of this guideline is to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of In-111-pentetreotide scintigraphy.

引用

页码：1441 / 1448

页数：8

共 34 条

[1]

[Anonymous], 2008, ANN ICRP, V38, P1

[2] Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: New prognostic factors for malignant well-differentiated endocrine tumors [J].

Asnacios, Amani ;

Courbon, Frederic ;

Rochaix, Philippe ;

Bauvin, Eric ;

Cances-Lauwers, Valerie ;

Susini, Christiane ;

Schulz, Stefan ;

Boneu, Andree ;

Guimbaud, Rosine ;

Buscail, Louis .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (06) :963-970

[3]

Balon HR, 2001, J NUCL MED, V42, P1134

[4]

Briganti V, 1997, CLIN CANCER RES, V3, P2385

[5] Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours [J].

Chiti, A ;

Fanti, S ;

Savelli, G ;

Romeo, A ;

Bellanova, B ;

Rodari, M ;

van Graafeiland, BJ ;

Monetti, N ;

Bombardieri, E .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (10) :1396-1403

[6]

Chiti A, 2000, Q J NUCL MED, V44, P42

[7] Somatostatin receptor scintigraphy: Its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas - A prospective study [J].

Gibril, F ;

Reynolds, JC ;

Doppman, JL ;

Chen, CC ;

Venzon, DJ ;

Termanini, B ;

Weber, C ;

Stewart, CA ;

Jensen, RT .

ANNALS OF INTERNAL MEDICINE, 1996, 125 (01) :26-+

[8]

Gibril F, 1999, J NUCL MED, V40, P539

[9]

ICRP, 1998, ANN ICRP, V28, P3

[10]

ICRP, 1988, Ann ICRp, V18

← 1 2 3 4 →